News brief­ing: Jef­frey Lei­den to chair Tmu­ni­ty board of di­rec­tors; Op­di­vo wins new ap­proval in ad­vanced RCC

Long­time Ver­tex CEO Jef­frey Lei­den is tak­ing on a new role.

Lei­den has been ap­point­ed chair­man of Tmu­ni­ty’s board of di­rec­tors, the com­pa­ny an­nounced Mon­day. The move comes about a year and a half af­ter Lei­den an­nounced he’d be step­ping down from his po­si­tion at Ver­tex.

Ver­tex saw im­mense growth un­der Lei­den, lead­ing the com­pa­ny from its ex­it out of he­pati­tis C, when cures were mov­ing in, and in­to cys­tic fi­bro­sis. The com­pa­ny’s cys­tic fi­bro­sis triple com­bo ther­a­py Trikaf­ta is al­ready its best-sell­er, reach­ing the dis­tinc­tion just six weeks af­ter launch and record­ing the strongest first quar­ter of sales for any drug, per some es­ti­mates.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER